OFFICIAL - SENSITIVE COMMERCIAL Immunoglobulin Procurement Update 14th December 2018 Commercial Medicines Unit OFFICIAL - SENSITIVE COMMERCIAL
OFFICIAL - SENSITIVE COMMERCIAL Who Are We & What Do We Do? CMU (Commercial Medicines Unit) Specialised Commissioning National & Regional Frameworks NHS Secondary Care Medicines Analysis SRM Commercial Medicines Unit OFFICIAL - SENSITIVE COMMERCIAL
OFFICIAL - SENSITIVE COMMERCIAL Why Do We Do What We Do? CMU Market Management Innovation Quality Equality Standardisation Economies of Scale Law Commercial Medicines Unit OFFICIAL - SENSITIVE COMMERCIAL
OFFICIAL - SENSITIVE COMMERCIAL Framework – Then & Now June 15 – May 16 5.40m Grams June 16 – May 17 5.69m Grams (+5.4%) July 17 – June 18 6.17m Grams (+8.4%) July 18 – June 19 6.78m Grams (+9.9%) Commercial Medicines Unit OFFICIAL - SENSITIVE COMMERCIAL
OFFICIAL - SENSITIVE COMMERCIAL Framework – The Future Access to Stock Price Availability Extension and Beyond The B Word Statutory Pricing Scheme Medicines Optimisation https://www.england.nhs.uk/medicines/medicines-optimisation/ Commercial Medicines Unit OFFICIAL - SENSITIVE COMMERCIAL
OFFICIAL - SENSITIVE COMMERCIAL The Global Market Demand 10 – 12% Growth Pricing IVIg – $55 per gram (£43 per gram) SCIg – $63 per gram (£49 per gram) Impact Infrastructure Plasma Far East Exchange Rates Commercial Medicines Unit OFFICIAL - SENSITIVE COMMERCIAL
OFFICIAL - SENSITIVE COMMERCIAL What Are We Asking? Database 5.49m Grams Recorded (Year 1) 6.17m Grams Sales Data (Year 1) 89% Complete Volumes Forecasts 43% Year 1 Response Rate 90% Year 2 Allocation Response Rate Trust Engagement Commercial Medicines Unit OFFICIAL - SENSITIVE COMMERCIAL
Questions? darryn.boardman@nhs.net 01138 070 456 07702 410 392 Commercial Medicines Unit OFFICIAL - SENSITIVE COMMERCIAL